Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking. Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R. Sci Rep. 2022 Aug 30;12(1):14754.

30 Aug 2022
0

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Sci Rep. 2022 Aug 30;12(1):14754.

Tags

Share this

Related Posts

Klumthong, K.; Chalermsub, P.; Sopha, P.; Ruchirawat, S.; Ploypradith, P. An Expeditious Modular Hybrid Strategy for the Diversity-Oriented Synthesis of Lamellarins/Azalamellarins with Anticancer Cytotoxicity. J. Org. Chem. 2021, 86, 14883–14902.
Gene cloning and characterization of a novel highly organic solvent tolerant lipase from Proteus sp. SW1 and its application for biodiesel production. Whangsuk W, Sungkeeree P, Thiengmag S, Kerdwong J, Sallabhan R, Mongkolsuk S, Loprasert S Mol Biotechnol53p55-62(2013 Jan)

Recent Posts